Earnings History Data for Xenon Pharmaceuticals Inc. (XENE) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of medicines through the application of its proprietary discovery platform, which it refer to as Extreme Genetics. Xenon is developing proprietary product candidates for the treatment of both orphan as well as more prevalent diseases. The company offers Glybera (R), a gene therapy for the treatment of lipoprotein lipase deficiency, an orphan disorder. Xenon Pharmaceuticals Inc. is headquartered in Burnaby, Canada.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
29-02-2024	AH		XENE	Xenon Pharmaceuticals Inc.	3,210	-0.64	-0.77	-0.57	Xenon Pharma GAAP EPS of -$0.64 beats by $0.12 [2/29/2024 4:05 PM]	46.76	-0.45 (-0.94%)	47.20	0.0 (0.00%)	27.99 - 50.99	650,574	430,000	43,427
Xenon Pharma GAAP EPS of -$0.64 beats by $0.12 [2/29/2024 4:05 PM]
08-11-2023	AH		XENE	Xenon Pharmaceuticals Inc.	2,110	-0.73	-0.75	-0.57	Xenon Pharma GAAP EPS of -$0.73 beats by $0.04 [11/8/2023 4:28 PM]	30.07	-2.08 (-6.47%)	32.15	0.0 (0.00%)	29.67 - 43.75	1,954,005	580,000	41,018
Xenon Pharma GAAP EPS of -$0.73 beats by $0.04 [11/8/2023 4:28 PM]
09-08-2023	AH		XENE	Xenon Pharmaceuticals Inc.	2,260	-0.72	-0.69	-0.55	Xenon Pharma GAAP EPS of -$0.72 misses by $0.01 [8/9/2023 4:03 PM]	38.44	2.99 (8.43%)	35.45	0.0 (0.00%)	31.79 - 43.75	825,933	340,000	3,747
Xenon Pharma GAAP EPS of -$0.72 misses by $0.01 [8/9/2023 4:03 PM]
09-05-2023	AH	4:00 PM ET (May 9)	XENE	Xenon Pharmaceuticals Inc.	2,670	-0.63	-0.62	-0.35	Xenon Pharma GAAP EPS of -$0.63 beats by $0.01 [5/9/2023 4:47 PM]	41.19	-2.35 (-5.41%)	43.54	0.0 (0.00%)	25.08 - 43.57	750,115	410,000	5,473
Xenon Pharma GAAP EPS of -$0.63 beats by $0.01 [5/9/2023 4:47 PM]
01-03-2023	AH	4:00 PM ET (Mar 1)	XENE	Xenon Pharmaceuticals Inc.	2,320	-0.57	-0.58	-0.57	Xenon Pharma GAAP EPS of -$0.57 beats by $0.02 [3/1/2023 4:03 PM]	37.38	-2.97 (-7.36%)	40.35	0.0 (0.00%)	24.94 - 41.39	1,273,800	350,000	8,406
Xenon Pharma GAAP EPS of -$0.57 beats by $0.02 [3/1/2023 4:03 PM]
08-11-2022	AH	4:00 PM ET (Nov 8)	XENE	Xenon Pharmaceuticals Inc.	2,280	-0.57	-0.52	-0.36	Xenon Pharma GAAP EPS of -$0.57 misses by $0.05, revenue of $0.13M misses by $2.89M [11/8/2022 4:08 PM]	33.18	-2.22 (-6.27%)	35.40	0.0 (0.00%)	23.26 - 41.39	859,914	370,000	8,022
Xenon Pharma GAAP EPS of -$0.57 misses by $0.05, revenue of $0.13M misses by $2.89M [11/8/2022 4:08 PM] Xenon Pharmaceuticals Strengthens Leadership Team with Appointment of Andrea DiFabio as Chief Legal Officer and Corporate Secretary [Nov-07-22 08:30AM]
09-08-2022	AH	4:30 PM ET (Aug 9)	XENE	Xenon Pharmaceuticals Inc.	2,020	-0.55	-0.49	-0.51	Xenon Pharma GAAP EPS of -$0.55 misses by $0.06, revenue of $0.54M misses by $2.71M [8/9/2022 5:02 PM]	39.80	0.45 (1.14%)	40.00	0.65 (1.65%)	14.65 - 40.92	524,051	470,000	7,016
Xenon Pharma GAAP EPS of -$0.55 misses by $0.06, revenue of $0.54M misses by $2.71M [8/9/2022 5:02 PM] Xenon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update [Aug-09-22 04:01PM] Xenon Pharmaceuticals to Present at the 13th Annual Wedbush PacGrow Healthcare Conference [Aug-08-22 08:30AM]
10-05-2022	AH	4:00 PM ET (May 10)	XENE	Xenon Pharmaceuticals Inc.	1,450	-0.35	-0.38	-0.42	Xenon Pharma GAAP EPS of -$0.35 beats by $0.07, revenue of $8.77M beats by $1.03M [5/10/2022 4:13 PM]	26.93	-1.64 (-5.74%)	28.57	0.0 (0.00%)	14.65 - 36.42	589,805	590,000	12,687
Xenon Pharma GAAP EPS of -$0.35 beats by $0.07, revenue of $8.77M beats by $1.03M [5/10/2022 4:13 PM] Syndax Pharmaceuticals (SNDX) Reports Q1 Loss, Lags Revenue Estimates [May-09-22 06:25PM] Xenon Pharmaceuticals (XENE) Reports Q1 Loss, Misses Revenue Estimates [May-10-22 05:45PM] Xenon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update [May-10-22 04:01PM]
01-03-2022	AH	4:00 PM ET (Mar 1)	XENE	Xenon Pharmaceuticals Inc.	1,600	-0.57	-0.47	-0.34	Xenon Pharma GAAP EPS of -$1.77 misses by $1.41, revenue of $18.43M beats by $12.13M [3/1/2022 4:06 PM]	32.77	1.01 (3.18%)	31.76	0.0 (0.00%)	14.65 - 36.42	443,022	400,000	2,425
Xenon Pharma GAAP EPS of -$1.77 misses by $1.41, revenue of $18.43M beats by $12.13M [3/1/2022 4:06 PM] Xenon Pharmaceuticals Reports 2021 Financial Results and Provides Corporate Update [Mar-01-22 04:01PM] Xenon Pharmaceuticals (XENE) Reports Q4 Loss, Lags Revenue Estimates [Mar-01-22 05:25PM]
10-11-2021	AH	4:00 PM ET (Nov 10)	XENE	Xenon Pharmaceuticals Inc.	1,820	-0.36	-0.44	-0.25	Xenon Pharma EPS beats by $0.01, misses on revenue [11/10/2021 4:03 PM]	31.47	-2.32 (-6.87%)	33.79	0.0 (0.00%)	9.99 - 36.42	793,078	550,000	5,230
Xenon Pharma EPS beats by $0.01, misses on revenue [11/10/2021 4:03 PM] Xenon Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update [Nov-10-21 04:01PM] Xenon Pharmaceuticals (XENE) Reports Q3 Loss, Tops Revenue Estimates [Nov-10-21 05:15PM]
11-08-2021	AH	4:00 PM ET (Aug 11)	XENE	Xenon Pharmaceuticals Inc.	675.96	-0.51	-0.49	0.00	Xenon Pharma EPS misses by $0.03, misses on revenue [8/11/2021 4:05 PM]	17.94	-0.74 (-3.96%)	18.60	-0.08 (-0.43%)	9.32 - 21.94	210,113	210,000	656
Xenon Pharma EPS misses by $0.03, misses on revenue [8/11/2021 4:05 PM] Xenon Pharmaceuticals to Participate in the 12th Annual Wedbush PacGrow Healthcare Conference [Aug-10-21 05:53PM] Xenon Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update [Aug-11-21 04:01PM] Xenon Pharmaceuticals (XENE) Reports Q2 Loss, Lags Revenue Estimates [Aug-11-21 05:35PM] 10 Best Small-Cap Stocks to Buy According to Hedge Funds [Aug-12-21 10:46AM]
11-05-2021	AH	4:00 PM ET (May 11)	XENE	Xenon Pharmaceuticals Inc.	758.22	-0.42	-0.45	-0.22	Xenon Pharma EPS beats by $0.01, beats on revenue [5/11/2021 4:13 PM]	17.46	-0.47 (-2.62%)	18.35	0.19 (1.05%)	9.32 - 21.94	107,883	100,000	1
Xenon Pharma EPS beats by $0.01, beats on revenue [5/11/2021 4:13 PM] Xenon Pharmaceuticals, Inc. to Host Earnings Call [May-11-21 02:30PM] Xenon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update [May-11-21 04:01PM]
01-03-2021	AH		XENE	Xenon Pharmaceuticals Inc.	523.01	-0.34	-0.40	-0.42	Xenon Pharma EPS beats by $0.06, beats on revenue [3/1/2021 4:21 PM]	20.12	2.20 (12.30%)	17.92	0.0 (0.00%)	7.00 - 21.87	439,834	212,914	1,754
Xenon Pharma EPS beats by $0.06, beats on revenue [3/1/2021 4:21 PM] Xenon Pharmaceuticals (XENE) Reports Q4 Loss, Tops Revenue Estimates [Mar-01-21 06:25PM] Recap: Xenon Pharmaceuticals Q4 Earnings [Mar-01-21 05:25PM]
05-11-2020	AH	4:00 PM ET (Nov 5)	XENE	Xenon Pharmaceuticals Inc.	384.24	-0.25	-0.15	-0.33	Xenon Pharma EPS misses by $0.14, misses on revenue [11/5/2020 5:01 PM]	10.98	-0.88 (-7.38%)	11.50	0.27 (2.40%)	7.00 - 18.45	286,213	140,530	561

06-08-2020	AH	4:00 PM ET (Aug 6)	XENE	Xenon Pharmaceuticals Inc.	402.90	N/A	-0.24	-0.37	Xenon Pharma EPS beats by $0.24, beats on revenue [8/6/2020 4:11 PM]	11.08	-0.22 (-1.95%)	11.30	0.0 (0.00%)	7.00 - 18.45	119,944	107,166	2,967

21-05-2020	AH	4:00 PM ET (May 21)	XENE	Xenon Pharmaceuticals Inc.	500.92	-0.22	-0.31	-0.42	Xenon Pharma EPS beats by $0.10, beats on revenue [5/21/2020 4:03 PM]	15.24	1.37 (9.88%)	0.0	0.0 (0.00%)	7.00 - 18.45	342,090	118,066	0